inflammatogenic
alloantibody
-les-
antiserum
nacolomab tafenatox
presentation
agonistic monoclonal antibody
inflammopathology
atezolizumab
immunoinflammatory
vapaliximab
immunosorbing
soravtansine
dorlixizumab
teplizumab
mitumomab
-ner-
monospecific
bezlotoxumab
secukinumab
-lim-
C-reactive protein
CRP
brentuximab
antipolyvalent
alirocumab
sasanlimab
solitomab
inflammomodulatory
antiphlogistic
nofetumomab
evolocumab
toripalimab
antiinflammation
pozelimab
monoantibody
vanucizumab
-mab
dinutuximab
sintilimab
zenocutuzumab
retifanlimab
ziltivekimab
fanolesomab
amatuximab
sifalimumab
zanolimumab
pancytokeratin
inflammogenic
avdoralimab